Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rifabutin with Clarithromycin/Ethambutol for MAC Bacteremia in AIDS
NCT00002101Phase 3Completed
- Sponsor
- Pharmacia
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of rifabutin in Mycobacterium avium complex infection (MAC) (3 arms), sponsored by Pharmacia. Primary endpoint: Reduction in Colony-Forming Units at 16 weeks. Status: completed.
02
Drugs
rifabutin
03
Conditions
Mycobacterium avium complex infection (MAC)
Beyond the preview
Go deeper on NCT00002101.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002101.